MedTrace Logo

Correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic Fibrosis in MASlD With type2 Diabetes Mellitus

NCT06715189 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2024-12-04

No results posted yet for this study

Summary

Metabolic dysfunction asociated steatotic liver disease prevalence is 25%world wide diabetic patients have a risk for MASLD then have hepatic fibrosis so we study correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic fibrosis In Metabolic dysfunction asociated steatotic liver disease in patients with type2 Diabetes Mellitus

Conditions

  • Hepatic Fibrosis

Interventions

DIAGNOSTIC_TEST

serum Adiponectine and Resistin

corrolation between serum adiponectin and Resistin levels and degree of hepatic fibrosis

DIAGNOSTIC_TEST

fibroscan

hepatic fibrosis detection in type 2 diabetes mellutis

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-01
Primary Completion
2025-12-01
Completion
2025-12-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06715189 on ClinicalTrials.gov